Picture of ConvaTec logo

CTEC ConvaTec News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

REG - Convatec Group PLC - Convatec Group PLC: Results of AGM

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240516:nRSP7990Oa&default-theme=true

RNS Number : 7990O  Convatec Group PLC  16 May 2024

Convatec Group Plc

 

Results of Annual General Meeting

 

London, United Kingdom (16 May 2024) - Poll Result

Convatec Group Plc ("Convatec") held its Annual General Meeting today
("AGM"). The results of the poll held in relation to the resolutions proposed
at the AGM are set out below

 

                                                                                       For (see note 2)                     Against (see note 2)                                   Votes Total               % of ISC Voted  Votes Witheld

                                                                                                                                                                                   (excluding withheld)
 Resolution                                                                            No of shares              %          No of Shares                              %
 1       To receive the Annual Report and Accounts 2023                                      1,852,466,756       100.00%                       353                    0.00%              1,852,467,109       90.37%                1,291,713
 2       To approve the Directors' Remuneration Report                                       1,813,185,796       98.24%             32,521,511                        1.76%              1,845,707,307       90.04%                8,051,515
 3       To declare Final Dividend                                                           1,853,744,153       100.00%                  12,049                      0.00%              1,853,756,202       90.44%                      2,620
 4       To re-elect Dr John McAdam as a Director                                            1,847,283,011       99.65%               6,442,175                       0.35%              1,853,725,186       90.43%                     33,636
 5       To re-elect Karim Bitar as a Director                                               1,848,145,807       99.70%               5,582,073                       0.30%              1,853,727,880       90.44%                     30,942
 6       To re-elect Jonny Mason as a Director                                               1,848,076,960       99.70%               5,632,063                       0.30%              1,853,709,023       90.43%                     49,799
 7       To re-elect Margaret Ewing as a Director                                            1,816,225,341       97.98%             37,483,741                        2.02%              1,853,709,082       90.43%                     49,740
 8       To re-elect Brian May as a Director                                                 1,846,602,408       99.62%               7,118,004                       0.38%              1,853,720,412       90.43%                     38,410
 9       To re-elect Professor Constantin Coussios as a Director                             1,846,585,982       99.61%               7,143,987                       0.39%              1,853,729,969       90.44%                     28,853
 10      To re-elect Heather Mason as a Director                                             1,805,072,326       97.38%             48,629,636                        2.62%              1,853,701,962       90.43%                     56,860
 11      To re-elect Kim Lody as a Director                                                  1,846,589,957       99.62%               7,117,950                       0.38%              1,853,707,907       90.43%                     50,915
 12      To re-elect Sharon O'Keefe as a Director                                            1,846,493,634       99.61%               7,226,778                       0.39%              1,853,720,412       90.43%                     38,410
 13      To re-appoint Deloitte LLP as auditors                                              1,851,179,389       99.98%                  440,502                      0.02%              1,851,619,891       90.33%                2,137,431
 14      To authorise the Directors to agree the auditors' remuneration                      1,853,715,114       100.00%                  19,198                      0.00%              1,853,734,312       90.44%                     24,510
 15      To approve an amendment to the Company's LTIP rules to reflect the increased        1,837,845,100       99.14%             15,882,668                        0.86%              1,853,727,768       90.44%                     31,054
         maximum award limit set out for executive directors in the Company's
         prevailing Directors' Remuneration policy.
 16      To authorise political donations and political expenditure                          1,836,103,687       99.07%             17,229,247                        0.93%              1,853,332,934       90.42%                   425,888
 17      To authorise the Directors to allot shares                                          1,710,658,359       92.28%           143,073,563                         7.72%              1,853,731,922       90.44%                     26,900
 18      To authorise the Directors to disapply pre-emption rights*                          1,711,441,065       92.34%           142,042,010                         7.66%              1,853,483,075       90.42%                   275,747
         To authorise the Directors to disapply pre-emption rights in connection with        1,664,945,067       90.18%           181,388,202                         9.82%              1,846,333,269       90.07%                7,425,553

       an acquisition or specified capital investment*

 19

 20      To authorise the Directors to make market purchases of own shares*                  1,850,913,656       99.88%               2,233,348                       0.12%              1,853,147,004       90.41%                   611,818
 21      To authorise the calling of a general meetings on 14 clear days' notice*            1,795,351,922       96.85%             58,406,900                        3.15%              1,853,758,822       90.44%                            0

 

*Special Resolution

NOTES:

1.   All resolutions were passed.

2.   Votes "For" and "Against" are expressed as a percentage of votes
received.

3.   A "Vote withheld" is not a vote in law and is not counted in the
calculation of the votes "For" or "Against" a resolution.

4.   Total number of shares in issue is 2,049,789,559 (90.44% of capital was
voted).

5.   Computershare acted as scrutineer of the poll on all resolutions.

 

In accordance with Listing Rule 9.6.2, copies of the resolutions that do not
constitute ordinary business that were passed at the Annual General Meeting
have been submitted to the National Storage Mechanism and will be available
for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

 

Enquiries 

 

Ria Banerjee, Group Deputy Company
Secretary
                      +44(0)7425 655 845

 

Cosec@convatec.com

 

Convatec Group Plc's LEI code is 213800LS272L4FIDOH92 

 

 

About Convatec 

 

Pioneering trusted medical solutions to improve the lives we touch: Convatec
is a global medical products and technologies company, focused on solutions
for the management of chronic conditions, with leading positions in advanced
wound care, ostomy care, continence care and infusion care. With around 10,000
colleagues, we provide our products and services in almost 100 countries,
united by a promise to be forever caring. Our solutions provide a range of
benefits, from infection prevention and protection of at-risk skin, to
improved patient outcomes and reduced care costs. Group revenues in 2023 were
over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:
CTEC). To learn more about Convatec, please visit www.convatecgroup.com
(http://www.convatecgroup.com)

 

 

 

# # #

END

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGQKABPPBKDFPD

Recent news on ConvaTec

See all news